Russell Investments Group’s PDL BioPharma, Inc. PDLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-196,783
| Closed | -$485K | – | 3283 |
|
|
2020
Q4 | $485K | Sell |
196,783
-633,097
| -76% | -$1.56M | ﹤0.01% | 2445 |
|
|
2020
Q3 | $2.62M | Buy |
829,880
+123,496
| +17% | +$389K | 0.01% | 1513 |
|
|
2020
Q2 | $2.05M | Buy |
706,384
+26,954
| +4% | +$78.4K | ﹤0.01% | 1612 |
|
|
2020
Q1 | $1.92M | Sell |
679,430
-326,532
| -32% | -$920K | 0.01% | 1489 |
|
|
2019
Q4 | $3.26M | Buy |
1,005,962
+73,578
| +8% | +$239K | 0.01% | 1459 |
|
|
2019
Q3 | $2.02M | Buy |
932,384
+498,528
| +115% | +$1.08M | ﹤0.01% | 1681 |
|
|
2019
Q2 | $1.36M | Sell |
433,856
-70,335
| -14% | -$221K | ﹤0.01% | 1859 |
|
|
2019
Q1 | $1.88M | Sell |
504,191
-95,659
| -16% | -$356K | ﹤0.01% | 1750 |
|
|
2018
Q4 | $1.73M | Sell |
599,850
-165,782
| -22% | -$477K | ﹤0.01% | 1683 |
|
|
2018
Q3 | $2.01M | Sell |
765,632
-422,489
| -36% | -$1.11M | ﹤0.01% | 1750 |
|
|
2018
Q2 | $2.77M | Sell |
1,188,121
-1,060,343
| -47% | -$2.47M | 0.01% | 1597 |
|
|
2018
Q1 | $6.61M | Buy |
2,248,464
+225,698
| +11% | +$664K | 0.01% | 1198 |
|
|
2017
Q4 | $5.85M | Sell |
2,022,766
-14,900
| -0.7% | -$43.1K | 0.01% | 1254 |
|
|
2017
Q3 | $6.91M | Buy |
2,037,666
+87,888
| +5% | +$298K | 0.01% | 1112 |
|
|
2017
Q2 | $4.82M | Sell |
1,949,778
-235,953
| -11% | -$583K | 0.01% | 1262 |
|
|
2017
Q1 | $4.96M | Buy |
2,185,731
+249,671
| +13% | +$567K | 0.01% | 1215 |
|
|
2016
Q4 | $4.1M | Buy |
+1,936,060
| New | +$4.1M | 0.01% | 1362 |
|